The longitudinal dynamics and natural history of clonal haematopoiesis

Margarete A. Fabre(Wellcome/MRC Cambridge Stem Cell Institute), José Guilherme de Almeida(European Bioinformatics Institute), Edoardo Fiorillo(Institute of Genetic and Biomedical Research), Emily Mitchell(Wellcome/MRC Cambridge Stem Cell Institute), Aristi Damaskou(Wellcome/MRC Cambridge Stem Cell Institute), Justyna Rak(Wellcome/MRC Cambridge Stem Cell Institute), Valeria Orrù(Institute of Genetic and Biomedical Research), Michele Marongiu(Institute of Genetic and Biomedical Research), Michael Spencer Chapman(Wellcome/MRC Cambridge Stem Cell Institute), M. S. Vijayabaskar(Wellcome/MRC Cambridge Stem Cell Institute), E. Joanna Baxter(Wellcome/MRC Cambridge Stem Cell Institute), Claire Hardy(Wellcome Sanger Institute), Federico Abascal(Wellcome Sanger Institute), Nicholas Williams(Wellcome/MRC Cambridge Stem Cell Institute), Jyoti Nangalia(Wellcome/MRC Cambridge Stem Cell Institute), Iñigo Martincorena(Wellcome Sanger Institute), Peter J. Campbell(Wellcome/MRC Cambridge Stem Cell Institute), Eoin McKinney(University of Cambridge), Francesco Cucca(University of Sassari), Moritz Gerstung(European Bioinformatics Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute)
Nature
June 1, 2022
Cited by 359Open Access
Full Text

Abstract

Abstract Clonal expansions driven by somatic mutations become pervasive across human tissues with age, including in the haematopoietic system, where the phenomenon is termed clonal haematopoiesis 1–4 . The understanding of how and when clonal haematopoiesis develops, the factors that govern its behaviour, how it interacts with ageing and how these variables relate to malignant progression remains limited 5,6 . Here we track 697 clonal haematopoiesis clones from 385 individuals 55 years of age or older over a median of 13 years. We find that 92.4% of clones expanded at a stable exponential rate over the study period, with different mutations driving substantially different growth rates, ranging from 5% ( DNMT3A and TP53 ) to more than 50% per year ( SRSF2 P95H ). Growth rates of clones with the same mutation differed by approximately ±5% per year, proportionately affecting slow drivers more substantially. By combining our time-series data with phylogenetic analysis of 1,731 whole-genome sequences of haematopoietic colonies from 7 individuals from an older age group, we reveal distinct patterns of lifelong clonal behaviour. DNMT3A -mutant clones preferentially expanded early in life and displayed slower growth in old age, in the context of an increasingly competitive oligoclonal landscape. By contrast, splicing gene mutations drove expansion only later in life, whereas TET2 -mutant clones emerged across all ages. Finally, we show that mutations driving faster clonal growth carry a higher risk of malignant progression. Our findings characterize the lifelong natural history of clonal haematopoiesis and give fundamental insights into the interactions between somatic mutation, ageing and clonal selection.


Related Papers

No related papers found

Powered by citation graph analysis